Sorrento Therapeutics (SRNE) Announces Positive Phase II Res

Sorrento Therapeutics (SRNE) Announces Positive Phase II Results of PD-L1 Checkpoint Inhibitor IMC-001 Presented at Asian Congress of the European Society for Medical Oncology

Sorrento Therapeutics (SRNE) Announces Positive Phase II Results of PD-L1 Checkpoint Inhibitor IMC-001 Presented at Asian Congress of the European Society for Medical Oncology
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

China , Yuhan , Anhui , South Korea , Seog Kim , Henry Ji , Immuneoncia Seongnam , Sorrento Therapeutics Inc , Samsung Medical Center , Immuneoncia Therapeutics , Asian Congress , Yuhan Corporation Of Korea , European Society For Medical Oncology , Nasdaq , Yuhan Corporation , European Society , Medical Oncology , Won Seog Kim , Principal Investigator , Tae Kim , Chief Executive Officer ,